iThera Medical

iThera Medical

Private
MunichHealthcare & Life Scienceshttp://ithera-medical.com

Last Round

Series D

Dec 21, 2022

Total Funding Raised

$41.88M

Company Overview

iThera Medical is a diagnostic equipment company that develops and markets biomedical imaging systems based on Multispectral Optoacoustic Tomography (MSOT) for preclinical and clinical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

multispectral optoacoustic tomographyMSOToptoacoustic imagingphotoacoustic imagingbiomedical imagingmedical imaging systemspreclinical imagingnon-invasive diagnosticsclinical imagingmolecular imagingfunctional imagingsmall animal imagingIBD imagingcancer imagingRSOMphotoacoustic effect

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iThera Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

iThera Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DDec 21, 2022
GrantApr 1, 2022
GrantOct 15, 2021
Series CDec 18, 2018
Series CSep 18, 2018
Series A
Nov 23, 2011

Key People

Founding team and executive leadership

Chris Parkhill

Group CFO

Executive Team

iThera Medical Investors

Notable investors and investment history

InvestorRounds
Mey Capital MatrixSeries D, Series A
European Innovation CouncilGrant
EXTORELSeries C
TRUMPF VentureSeries D
AscenionSeries A
Wachstumsfonds BayernSeries D, Series C
FluxunitSeries D, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2025

    Launched new optoacoustic imaging solution for clinical applications with Trumpf.

  • Jan 28, 2025

    Showcased new optoacoustic imaging solution at Photonics West.

iThera Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iThera Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iThera Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range14
Year Founded2010
Last FundingDec 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.